KIDS Orthopediatrics Corp

Price (delayed)

$69.75

Market cap

$1.37B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.07

Enterprise value

$1.38B

Highlights
The revenue rose by 7% since the previous quarter and by 2.6% year-on-year
The gross profit has increased by 7% since the previous quarter and by 5% year-on-year
The equity has surged by 60% year-on-year but it has declined by 5% since the previous quarter
The net income has plunged by 145% YoY and by 16% from the previous quarter
The EPS has dropped by 101% year-on-year and by 14% since the previous quarter

Key stats

What are the main financial stats of KIDS
Market
Shares outstanding
19.66M
Market cap
$1.37B
Enterprise value
$1.38B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.17
Price to sales (P/S)
17.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.05
Earnings
Revenue
$76.18M
EBIT
-$35.65M
EBITDA
-$26.48M
Free cash flow
-$22.79M
Per share
EPS
-$2.07
Free cash flow per share
-$1.19
Book value per share
$11.3
Revenue per share
$3.97
TBVPS
$9.39
Balance sheet
Total assets
$313.35M
Total liabilities
$91.21M
Debt
$26.8M
Equity
$222.15M
Working capital
$115.41M
Liquidity
Debt to equity
0.12
Current ratio
4.15
Quick ratio
2.59
Net debt/EBITDA
-0.15
Margins
EBITDA margin
-34.8%
Gross margin
77.6%
Net margin
-50.4%
Operating margin
-36.8%
Efficiency
Return on assets
-12.1%
Return on equity
-16.4%
Return on invested capital
-28.5%
Return on capital employed
-12.9%
Return on sales
-46.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

KIDS stock price

How has the Orthopediatrics stock price performed over time
Intraday
5.92%
1 week
15.1%
1 month
11.71%
1 year
45.98%
YTD
69.09%
QTD
10.4%

Financial performance

How have Orthopediatrics's revenue and profit performed over time
Revenue
$76.18M
Gross profit
$59.14M
Operating income
-$28.05M
Net income
-$38.38M
Gross margin
77.6%
Net margin
-50.4%
Orthopediatrics's operating income has shrunk by 155% YoY and by 4.9% QoQ
KIDS's operating margin has dropped by 149% year-on-year but it is up by 2.1% since the previous quarter
The net income has plunged by 145% YoY and by 16% from the previous quarter
KIDS's net margin has dropped by 139% year-on-year and by 9% since the previous quarter

Growth

What is Orthopediatrics's growth rate over time

Valuation

What is Orthopediatrics stock price valuation
P/E
N/A
P/B
6.17
P/S
17.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.05
The EPS has dropped by 101% year-on-year and by 14% since the previous quarter
The equity has surged by 60% year-on-year but it has declined by 5% since the previous quarter
The price to book (P/B) is 58% more than the last 4 quarters average of 3.7
KIDS's price to sales (P/S) is 44% higher than its last 4 quarters average of 11.5
The revenue rose by 7% since the previous quarter and by 2.6% year-on-year

Efficiency

How efficient is Orthopediatrics business performance
The return on sales has dropped by 189% year-on-year and by 10% since the previous quarter
KIDS's ROIC has plunged by 144% YoY and by 4.4% from the previous quarter
The return on assets has declined by 27% year-on-year and by 3.4% since the previous quarter
Orthopediatrics's ROE has decreased by 20% YoY and by 6% from the previous quarter

Dividends

What is KIDS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KIDS.

Financial health

How did Orthopediatrics financials performed over time
KIDS's total liabilities has surged by 161% year-on-year and by 6% since the previous quarter
Orthopediatrics's total assets has soared by 80% YoY but it has decreased by 2.2% from the previous quarter
KIDS's debt is 88% smaller than its equity
The equity has surged by 60% year-on-year but it has declined by 5% since the previous quarter
KIDS's debt is up by 27% year-on-year and by 2.3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.